Xiao Ling Jiang
Director/Board Member at Sunho Biologics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Liu Song Yin | M | 37 |
SunHo (China) Biopharmaceutical Co. Ltd.
Sunho Biologics, Inc.
 Sunho Biologics, Inc. BiotechnologyHealth Technology Sunho Biologics, Inc. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of biologics that modulate the immune microenvironment by directly modulating the innate and adaptive immune systems. The company was founded on May 14, 2021 and is headquartered in Huzhou, China. | 4 years |
| Feng Zhang | M | 51 |
SunHo (China) Biopharmaceutical Co. Ltd.
Sunho Biologics, Inc.
Sunho Biologics, Inc. BiotechnologyHealth Technology Sunho Biologics, Inc. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of biologics that modulate the immune microenvironment by directly modulating the innate and adaptive immune systems. The company was founded on May 14, 2021 and is headquartered in Huzhou, China. | 3 years |
| Chun Qin Xu | F | 45 |
SunHo (China) Biopharmaceutical Co. Ltd.
Sunho Biologics, Inc.
Sunho Biologics, Inc. BiotechnologyHealth Technology Sunho Biologics, Inc. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of biologics that modulate the immune microenvironment by directly modulating the innate and adaptive immune systems. The company was founded on May 14, 2021 and is headquartered in Huzhou, China. | 3 years |
| Lu Wen Shi | M | 60 |
Sunho Biologics, Inc.
Sunho Biologics, Inc. BiotechnologyHealth Technology Sunho Biologics, Inc. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of biologics that modulate the immune microenvironment by directly modulating the innate and adaptive immune systems. The company was founded on May 14, 2021 and is headquartered in Huzhou, China. | 1 years |
| Lan Feng | F | 45 |
Sunho Biologics, Inc.
Sunho Biologics, Inc. BiotechnologyHealth Technology Sunho Biologics, Inc. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of biologics that modulate the immune microenvironment by directly modulating the innate and adaptive immune systems. The company was founded on May 14, 2021 and is headquartered in Huzhou, China. | 1 years |
| Heung Wing Chan | M | 50 |
Sunho Biologics, Inc.
Sunho Biologics, Inc. BiotechnologyHealth Technology Sunho Biologics, Inc. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of biologics that modulate the immune microenvironment by directly modulating the innate and adaptive immune systems. The company was founded on May 14, 2021 and is headquartered in Huzhou, China. | 1 years |
| Bing Wang | M | 46 |
Nanjing University
| 17 years |
| Xiao Lin Xu | M | 47 |
Nanjing University
| 17 years |
| Hoi Ting Wong | F | 36 |
Sunho Biologics, Inc.
Sunho Biologics, Inc. BiotechnologyHealth Technology Sunho Biologics, Inc. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of biologics that modulate the immune microenvironment by directly modulating the innate and adaptive immune systems. The company was founded on May 14, 2021 and is headquartered in Huzhou, China. | 1 years |
| Rong Kui Fan | M | 32 |
Sunho Biologics, Inc.
Sunho Biologics, Inc. BiotechnologyHealth Technology Sunho Biologics, Inc. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of biologics that modulate the immune microenvironment by directly modulating the innate and adaptive immune systems. The company was founded on May 14, 2021 and is headquartered in Huzhou, China. | 1 years |
| Dong Cheng Jiang | M | 41 |
Sunho Biologics, Inc.
Sunho Biologics, Inc. BiotechnologyHealth Technology Sunho Biologics, Inc. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of biologics that modulate the immune microenvironment by directly modulating the innate and adaptive immune systems. The company was founded on May 14, 2021 and is headquartered in Huzhou, China. | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Zi Ye Zhao | M | 44 |
Nanjing University
| 10 years |
| Li Jun Zhang | M | 41 |
Nanjing University
| 4 years |
| Ying Mei Xin | F | 56 |
Nanjing University
| 2 years |
| Su Feng | M | 41 |
Nanjing University
| 1 years |
| Lin Cao | M | 45 |
Nanjing University
| 3 years |
| Liang Guo | M | 47 |
Nanjing University
| 2 years |
| Chen Zheng | M | 35 |
Nanjing University
| 4 years |
| Qiuchen Zhang | F | 47 |
Nanjing University
| 4 years |
| Fan Yang | M | 37 |
Nanjing University
| 4 years |
| Shuang Lu | F | 42 |
Nanjing University
| 1 years |
| Yan Ling She | F | 40 |
Nanjing University
| 1 years |
| Chao Yang Lu | M | 43 |
Nanjing University
| 4 years |
| Wen Rong Wang | M | 38 |
Nanjing University
| 4 years |
| Yan Yan Li | F | 56 |
Nanjing University
| 3 years |
| Yun Miao | F | 54 |
Nanjing University
| 1 years |
| Zheng Guang Lyu | M | - |
Nanjing University
| 2 years |
| Hou Jun Lu | M | 61 |
Nanjing University
| 3 years |
| Ying Ying Xu | F | 40 |
Nanjing University
| 7 years |
| Li Biao Chen | M | 42 |
Nanjing University
| 1 years |
| Bo Cheng | M | 51 |
Nanjing University
| 1 years |
| Zhu Shi | M | 54 |
Nanjing University
| 1 years |
| Hong Hong Wei | F | 38 |
Nanjing University
| 4 years |
| Jie Zhang | M | 48 |
Nanjing University
| 3 years |
| Jian Liu | M | 55 |
Nanjing University
| 2 years |
| Long Zhang | M | 47 |
Nanjing University
| 1 years |
| Zhen Fu Sun | M | 61 |
Nanjing University
| 2 years |
| Zhi Wei Huang | M | 75 |
Nanjing University
| 1 years |
| Tie Sheng Zhang | M | 50 |
Nanjing University
| 3 years |
| Hong Bo Zhu | M | 61 |
Nanjing University
| 3 years |
| Yi Min Xu | M | 61 |
Nanjing University
| 2 years |
| Hui Yuan Duan | M | 49 |
Nanjing University
| 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| China | 42 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Xiao Ling Jiang
- Personal Network
